Attenuation of in vitro host-pathogen interactions in quinolone-resistant Salmonella Typhi mutants.

OBJECTIVES The relationship between quinolone resistance acquisition and invasion impairment has been studied in some Salmonella enterica serovars. However, little information has been reported regarding the invasive human-restricted pathogen Salmonella Typhi. The aim of this study was to investigate the molecular mechanisms of quinolone resistance acquisition and its impact on virulence in this serovar. METHODS Two antibiotic-resistant mutants (Ty_c1 and Ty_c2) were generated from a Salmonella Typhi clinical isolate (Ty_wt). The three strains were compared in terms of antimicrobial susceptibility, molecular mechanisms of resistance, gene expression of virulence-related factors, ability to invade eukaryotic cells (human epithelial cells and macrophages) and cytokine production. RESULTS Multidrug resistance in Ty_c2 was attributed to AcrAB/TolC overproduction, decreased OmpF (both mediated by the mar regulon) and decreased OmpC. The two mutants showed a gradually reduced expression of virulence-related genes (invA, hilA, hilD, fliC and fimA), correlating with decreased motility, reduced infection of HeLa cells and impaired uptake by and intracellular survival in human macrophages. Moreover, Ty_c2 also showed reduced tviA expression. Additionally, we revealed a significant reduction in TNF-α and IL-1β production and decreased NF-κB activation. CONCLUSIONS In this study, we provide an in-depth characterization of the molecular mechanisms of antibiotic resistance in the Salmonella Typhi serovar and evidence that acquisition of antimicrobial resistance is concomitantly detected with a loss of virulence (epithelial cell invasion, macrophage phagocytosis and cytokine production). We suggest that the low prevalence of clinical isolates of Salmonella Typhi highly resistant to ciprofloxacin is due to poor immunogenicity and impaired dissemination ability of these isolates.

[1]  G. Woo,et al.  Increase of multidrug efflux pump expression in fluoroquinolone-resistant Salmonella mutants induced by ciprofloxacin selective pressure. , 2014, Research in veterinary science.

[2]  Haruo Watanabe,et al.  Antimicrobial Resistance in Salmonella enterica Serovar Typhi Isolates from Bangladesh, Indonesia, Taiwan, and Vietnam , 2014, Antimicrobial Agents and Chemotherapy.

[3]  J. Vila,et al.  Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica. , 2014, The Journal of antimicrobial chemotherapy.

[4]  A. Arkin,et al.  Genetic basis for nitrate resistance in Desulfovibrio strains , 2014, Front. Microbiol..

[5]  K. Thong,et al.  Variations in motility and biofilm formation of Salmonella enterica serovar Typhi , 2014, Gut Pathogens.

[6]  J. Vila,et al.  Molecular study of quinolone resistance mechanisms and clonal relationship of Salmonella enterica clinical isolates. , 2014, International journal of antimicrobial agents.

[7]  F. Weill,et al.  Lack of efflux mediated quinolone resistance in Salmonella enterica serovars Typhi and Paratyphi A , 2014, Front. Microbiol..

[8]  T. Loh,et al.  Prevalence of antibiotic resistance in lactic acid bacteria isolated from the faeces of broiler chicken in Malaysia , 2014, Gut Pathogens.

[9]  Y. Chuang,et al.  Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan , 2013, BMC Infectious Diseases.

[10]  J. Farrar,et al.  Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure , 2013, eLife.

[11]  C. Chiu,et al.  First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[12]  Pauliina Ilmonen,et al.  Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART , 2013, BMC Infectious Diseases.

[13]  J. Vila,et al.  Salmonella enterica Serovar Typhimurium Skills To Succeed in the Host: Virulence and Regulation , 2013, Clinical Microbiology Reviews.

[14]  S. Akira,et al.  Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. , 2013, Immunity.

[15]  James E. Robinson,et al.  Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV-Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross-Sectional Analysis , 2013, BMC Infectious Diseases.

[16]  T. van der Poll,et al.  Host–Pathogen Interaction in Invasive Salmonellosis , 2012, PLoS pathogens.

[17]  M. McClelland,et al.  Selection of Salmonella enterica Serovar Typhi Genes Involved during Interaction with Human Macrophages by Screening of a Transposon Mutant Library , 2012, PloS one.

[18]  S. Jain,et al.  Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis. , 2012, Microbiological research.

[19]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Shaohua Zhao,et al.  Differential Gene Expression by RamA in Ciprofloxacin-Resistant Salmonella Typhimurium , 2011, PloS one.

[21]  T. Butler.  Treatment of typhoid fever in the 21st century: promises and shortcomings. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  H. Andrews-Polymenis,et al.  A Rapid Change in Virulence Gene Expression during the Transition from the Intestinal Lumen into Tissue Promotes Systemic Dissemination of Salmonella , 2010, PLoS pathogens.

[23]  J. Wain,et al.  RamA, a Member of the AraC/XylS Family, Influences Both Virulence and Efflux in Salmonella enterica Serovar Typhimurium , 2010, Journal of bacteriology.

[24]  Yingchun Xu,et al.  Genetic Diversity of Salmonella enteric serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007 , 2010, BMC Microbiology.

[25]  K. Heuner,et al.  Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells , 2010, BMC Microbiology.

[26]  G. Klein,et al.  Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. , 2009, The Journal of antimicrobial chemotherapy.

[27]  J. Vila,et al.  Repression of Invasion Genes and Decreased Invasion in a High-Level Fluoroquinolone-Resistant Salmonella Typhimurium Mutant , 2009, PloS one.

[28]  S. Porwollik,et al.  Fitness Costs and Stability of a High-Level Ciprofloxacin Resistance Phenotype in Salmonella enterica Serotype Enteritidis: Reduced Infectivity Associated with Decreased Expression of Salmonella Pathogenicity Island 1 Genes , 2009, Antimicrobial Agents and Chemotherapy.

[29]  A. Falanga,et al.  Evidence for IL-6 promoter nuclear activation in U937 cells stimulated with Salmonella enterica serovar Typhimurium porins. , 2009, European cytokine network.

[30]  Lin Li,et al.  Quinolone-resistance in Salmonella is associated with decreased mRNA expression of virulence genes invA and avrA, growth and intracellular invasion and survival. , 2009, Veterinary microbiology.

[31]  E. Giralt,et al.  Mechanism of action of and resistance to quinolones , 2008, Microbial biotechnology.

[32]  Charles J. Dorman,et al.  Bacterial DNA topology and infectious disease , 2008, Nucleic acids research.

[33]  J. Pagés,et al.  Multiple Regulatory Pathways Associated with High-Level Ciprofloxacin and Multidrug Resistance in Salmonella enterica Serovar Enteritidis: Involvement of ramA and Other Global Regulators , 2008, Antimicrobial Agents and Chemotherapy.

[34]  F. Daigle.  Typhi genes expressed during infection or involved in pathogenesis. , 2008, Journal of infection in developing countries.

[35]  P. Bifani,et al.  Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? , 2008, Epidemiology and Infection.

[36]  H. Seth-Smith.  SPI-7: Salmonella's Vi-encoding Pathogenicity Island. , 2008, Journal of infection in developing countries.

[37]  G. Dougan,et al.  Interaction of Salmonella enterica serovar Typhi with cultured epithelial cells: roles of surface structures in adhesion and invasion. , 2008, Microbiology.

[38]  A. Cloeckaert,et al.  ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium , 2008, Antimicrobial Agents and Chemotherapy.

[39]  S. Nair,et al.  Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India. , 2008, International journal of antimicrobial agents.

[40]  M. Galas,et al.  CMY-2-type plasmid-mediated AmpC beta-lactamase finally emerging in Argentina. , 2008, International journal of antimicrobial agents.

[41]  J. Wain,et al.  Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones , 2007, Antimicrobial Agents and Chemotherapy.

[42]  M. Capoor,et al.  Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. , 2007, Journal of medical microbiology.

[43]  J. Pagés,et al.  Antibiotic Stress, Genetic Response and Altered Permeability of E. coli , 2007, PloS one.

[44]  D. Pillay,et al.  Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. , 2006, The Journal of antimicrobial chemotherapy.

[45]  S. Rubino,et al.  Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. , 2006, The Journal of antimicrobial chemotherapy.

[46]  I. Paulsen,et al.  Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials , 2006, Antimicrobial Agents and Chemotherapy.

[47]  B. Cookson,et al.  In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted , 2006, Molecular microbiology.

[48]  J. Bertin,et al.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages , 2006, Nature Immunology.

[49]  E. Threlfall,et al.  Drug-resistant enteric fever in the UK , 2006, The Lancet.

[50]  M. McClelland,et al.  Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Bahl,et al.  Typhoid and paratyphoid fever , 2005, The Lancet.

[52]  A. White,et al.  Prevalence of Mutations within the Quinolone Resistance-Determining Region of gyrA, gyrB, parC, and parE and Association with Antibiotic Resistance in Quinolone-Resistant Salmonella enterica , 2004, Antimicrobial Agents and Chemotherapy.

[53]  A. Cloeckaert,et al.  Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. , 2004, FEMS microbiology letters.

[54]  S. Falkow,et al.  Persistent bacterial infections: the interface of the pathogen and the host immune system , 2004, Nature Reviews Microbiology.

[55]  S. Kabra,et al.  Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. , 2004, Microbial drug resistance.

[56]  V. Ricci,et al.  Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica Serovar Typhimurium: Role in Multiple Antibiotic Resistance , 2004, Antimicrobial Agents and Chemotherapy.

[57]  A. Aderem,et al.  Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility , 2003, Nature Immunology.

[58]  E. Giraud,et al.  Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. , 2003, Journal of medical microbiology.

[59]  B. Jones,et al.  Transcription of the Salmonella Invasion Gene Activator, hilA, Requires HilD Activation in the Absence of Negative Regulators , 2003, Journal of bacteriology.

[60]  R. Skurray,et al.  Regulation of Bacterial Drug Export Systems , 2002, Microbiology and Molecular Biology Reviews.

[61]  Vanessa Sperandio,et al.  Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two‐component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli , 2002, Molecular microbiology.

[62]  N. Delihas,et al.  MicF: an antisense RNA gene involved in response of Escherichia coli to global stress factors. , 2001, Journal of molecular biology.

[63]  A. Cloeckaert,et al.  Mechanisms of quinolone resistance in Salmonella. , 2001, Veterinary research.

[64]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[65]  S. Levy,et al.  A soxRS-Constitutive Mutation Contributing to Antibiotic Resistance in a Clinical Isolate of Salmonella enterica (Serovar Typhimurium) , 2001, Antimicrobial Agents and Chemotherapy.

[66]  E. Threlfall,et al.  Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. , 2001, Emerging infectious diseases.

[67]  E. Giraud,et al.  Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium , 2000, Antimicrobial Agents and Chemotherapy.

[68]  J. Galán,et al.  The Flagellar Sigma Factor FliA (ς28) Regulates the Expression of Salmonella Genes Associated with the Centisome 63 Type III Secretion System , 2000, Infection and Immunity.

[69]  M. Sztein,et al.  Salmonella typhi Flagella Are Potent Inducers of Proinflammatory Cytokine Secretion by Human Monocytes , 1999, Infection and Immunity.

[70]  B. Iglewski,et al.  Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals , 1999, Journal of bacteriology.

[71]  S. Levy,et al.  Overexpression of the marA or soxSRegulatory Gene in Clinical Topoisomerase Mutants ofEscherichia coli , 1998, Antimicrobial Agents and Chemotherapy.

[72]  S. Levy,et al.  Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon , 1997, Antimicrobial agents and chemotherapy.

[73]  P. Miller,et al.  The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence , 1997, Journal of bacteriology.

[74]  M. Popoff,et al.  Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. , 1995, Microbiology.

[75]  J. Rosner,et al.  Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Y. Ohya,et al.  Transcriptional analysis of the flagellar regulon of Salmonella typhimurium , 1990, Journal of bacteriology.

[77]  T. Ezaki,et al.  Intact motility as a Salmonella typhi invasion-related factor , 1988, Infection and immunity.

[78]  A. B. CiusnE,et al.  Typhoid fever. , 1967, The Journal of the Arkansas Medical Society.